How Early Signals Prevent Risk In Clinical Trial Supply Chains

By Laura Hay, senior director of global program management at Trax Group | 2025 Winner, everywoman Customer/Passenger (Leader) Award

One of the biggest misconceptions about risk management is that it's about reacting to risks. In reality, by the time a risk appears on a dashboard, it has often been developing for weeks or even months.

Risks in clinical trial supply chains often begin as small deviations in enrollment patterns, RTSM behavior, or inventory positioning that are not immediately visible as exceptions. The best program managers don't just manage risks — they create the conditions that allow risks to be identified early, before they turn into issues.

Risk Management Is Really Signal Management

I've often said that program management is less about predicting the future and more about paying attention to the signals that others might overlook. Every major issue usually starts small. A delayed response. A missed commitment. A stakeholder who becomes disengaged. A resource that is stretched too thin. A decision that takes longer than expected. On their own, these may not seem significant, but together they often point to something bigger emerging.

Those early signals in clinical trial supply environments often show up through small shifts in forecast accuracy, RTSM allocation behavior, or depot replenishment timing that signal drift between planned and actual demand.

That's why I encourage teams to focus on leading indicators rather than lagging indicators. A missed milestone is a lagging indicator — the problem has already happened by the time you see it. But signs like slowing decision-making, low engagement in meetings, repeated action items, shifting priorities, or resource strain are leading indicators. They give you an early signal that something may be heading off track before delivery is impacted. Early indicators in clinical trial supply systems often include repeated RTSM overrides, increasing depot expedites, or growing variance between planned and actual inventory flow across sites.

The Value Of Early Signals Over Late Metrics

I often use the analogy of a pilot. A pilot doesn't wait until the aircraft is off course before checking the instruments. They're constantly making small adjustments based on what they're seeing in real time. Program managers need to operate the same way. Small corrections made early are far less costly and disruptive than major interventions later.

Risk in clinical trial supply systems often emerges through the interaction of demand signals, RTSM logic, and depot execution behavior, meaning small deviations can propagate quickly if not addressed early. Reducing risk starts with understanding the ecosystem around the program — dependencies, stakeholder expectations, resource availability, organizational priorities, decision-making processes, and potential points of failure.  That ecosystem includes depot network design, RTSM configuration, manufacturing lead times, and regulatory or import constraints that shape how supply flows actually perform against plan.

Many risks don't originate from the work itself. They come from assumptions: Assumptions that resources will be available when needed. Assumptions that decisions will be made on time. Assumptions that stakeholders share the same priorities. Assumptions that vendors interpret success the same way.

In clinical trial supply planning, those assumptions often relate to enrollment stability, forecast accuracy, RTSM behavior consistency, and depot capacity responding as expected under variable demand. One of the most valuable things a program manager can do is challenge those assumptions before they become problems.

Strong governance also plays a key role. Governance sometimes gets dismissed as bureaucracy, but when it works well, it's actually what creates clarity and speed. It defines how supply deviations are escalated, how conflicting priorities between patient needs and inventory constraints are resolved, and how decisions are made when signals from RTSM, forecasting, or depot performance do not align. It ensures people know who owns decisions, how issues are escalated, and where risks should be discussed. It creates a structure where concerns can be raised early, rather than surfaced only when it's too late to influence the outcome.

Trust is another critical element that is often underestimated in risk management.

People don't raise concerns if they fear blame. They don't escalate issues if they expect criticism. They don't share uncertainty if they feel they need to have all the answers first.

The strongest environments are those where early signals such as forecast variance, RTSM exceptions, or depot performance drift are treated as system inputs rather than individual performance issues. The strongest teams are the ones where people feel safe saying, "I'm concerned about this," even before they have all the facts.

Culture As The Foundation Of Risk Prevention

In many ways, risk management is really communication management.

I've seen programs recover from significant challenges because stakeholders were informed early and worked together to address issues. I've also seen relatively small problems escalate simply because no one wanted to raise the concern early enough.

One of my favorite quotes is from Warren Buffett: "Risk comes from not knowing what you're doing." Uncertainty in clinical trial supply systems often arises when forecasting assumptions, RTSM behavior, and actual enrollment velocity become misaligned without being detected through early signal monitoring.

For me, that doesn't mean every risk can be predicted. It means that the more visibility we create, the more openly we communicate, and the better we understand our environment, the fewer surprises we'll face.

Ultimately, great program managers aren't defined by how many problems they solve. They're defined by how many problems they prevent.

The most successful programs I've been part of didn't succeed because everything went smoothly. They succeeded because risks were identified early, discussed honestly, and addressed before they had the chance to impact delivery. That's what effective risk management looks like — not reacting to problems but stopping them from becoming problems in the first place. The best program managers aren't firefighters. They're smoke detectors. Their value isn't measured by how well they respond in a crisis — it's measured by how often they help the organization avoid one.

About The Author:

Laura Hay is a global supply chain leader specializing in program management, customer success, and account strategy. She has a proven track record of leading cross-functional teams to deliver complex, high-impact initiatives on time and within budget. Laura is known for building strong stakeholder relationships, driving operational excellence, and managing multimillion-dollar programs. She is passionate about connecting people, processes, and technology to build scalable, resilient supply chain solutions that deliver measurable business impact.